Skip to main content

ATP10A KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 4 bp deletion in exon 2.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human ATP10A knockout A549 cell line (AB267040), expandable thumbnail
  • Sanger Sequencing - Human ATP10A knockout A549 cell line (AB267040), expandable thumbnail

Key facts

Cell type
A549
Species or organism
Human
Tissue
Lung
Form
Liquid
Knockout validation
Sanger Sequencing
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 4 bp deletion in exon 2

Alternative names

Recommended products

ATP10A KO cell line available to order. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 4 bp deletion in exon 2.

Key facts

Cell type
A549
Form
Liquid
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 2 and 4 bp deletion in exon 2
Disease
Carcinoma
Concentration
Loading...

Properties

Gene name
ATP10A
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing

Quality control

STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level
EU: 1 US: 1
Adherent/suspension
Adherent
Gender
Male

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
  • Do not allow the cell density to exceed 7x104 cells/cm2.
Culture medium
F-12K + 10% FBS
Cryopreservation medium
Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Storage

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Notes

Recommended control: Human wild-type A549 cell line (ab255450). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

ATP10A also known as ATPase Class V type 10A is a protein involved in phospholipid transport. This protein is part of the P-type ATPase family characterized by its ability to catalyze ATP hydrolysis providing the energy needed for the transport of lipids across cell membranes. ATP10A has an approximate mass of 125 kDa. Expression of ATP10A occurs in various tissues with a higher concentration noted in the brain and adipose tissue.

Biological function summary

ATP10A contributes to maintaining the asymmetrical distribution of phospholipids in the cell membrane which is essential for cell function and integrity. This protein does not function alone; it associates with CDC50 to form a heterodimer complex important for its lipid translocase activity. This activity helps maintain cellular homeostasis impacting processes such as apoptosis and membrane curvature necessary for cell signaling and vesicle formation.

Pathways

The functional role of ATP10A integrates into lipid metabolism and cellular signaling pathways. ATP10A significantly impacts the phospholipid translocation pathway which regulates membrane dynamics and is associated with apoptosis-related proteins like scramblases. Within these pathways ATP10A also interacts with PI3K/AKT a signaling pathway important for cellular growth survival and metabolism.

Associated diseases and disorders

ATP10A holds importance in neurological and metabolic diseases. Altered expression or mutations in ATP10A appear linked to neurodevelopmental conditions such as Angelman syndrome where an imbalance in phospholipid transport may contribute to pathogenesis. Furthermore ATP10A associates with obesity-related disorders where its role in lipid metabolism links it to proteins like leptin which regulate energy balance and fat storage.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Sanger Sequencing - Human ATP10A knockout A549 cell line (ab267040), expandable thumbnail

    Sanger Sequencing - Human ATP10A knockout A549 cell line (ab267040)

    Allele-2: 1 bp insertion in exon 2.

  • Sanger Sequencing - Human ATP10A knockout A549 cell line (ab267040), expandable thumbnail

    Sanger Sequencing - Human ATP10A knockout A549 cell line (ab267040)

    Allele-1: 4 bp deletion in exon2

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com